Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marc Humbert, Christophe Guignabert, Sébastien Bonnet, Peter Dorfmüller, James R. Klinger, Mark R. Nicolls, Andrea J. Olschewski, Soni S. Pullamsetti, Ralph T. Schermuly, Kurt R. Stenmark, Marlene Rabinovitch. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018

Member's Comments

No comment yet.

Related content which might interest you: Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017 Year: 2017 State of the art: pulmonary hypertension Source: Breathe 2014; 10: 188-197 Year: 2014 Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance? Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020 Year: 2020 Pulmonary hypertension: basic concepts and practical management Source: Eur Respir J 2008; 31: 236-237 Year: 2008 Translational research in pulmonary hypertension: challenge and opportunity Source: Eur Respir J 2014; 43: 325-328 Year: 2013 Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013 State of the art in pulmonary hypertension Source: Virtual Congress 2020 – Chinese programme 2020: Part II Year: 2020 The importance of patient perspectives in pulmonary hypertension Source: Eur Respir J, 53 (1) 1801919; 10.1183/13993003.01919-2018 Year: 2019 Contemporary issues in pulmonary hypertension Source: Eur Respir Rev 2010 19: 266-271 Year: 2010 Clinical implications of the new concepts regarding COPD pathophysiology Source: Annual Congress 2008 - New insights into COPD pathophysiology Year: 2008 What have we learned from basic science studies on idiopathic pulmonary fibrosis? Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019 Year: 2019 Epigenetics and pulmonary diseases in the horizon of precision medicine: a review Source: Eur Respir J, 57 (6) 2003406; 10.1183/13993003.03406-2020 Year: 2021 Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances? Source: Eur Respir J 2016; 47: 388-389 Year: 2016 Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009 Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease” Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 The definition of pulmonary hypertension: history, practical implications and current controversies Source: Breathe, 17 (3) 210076; 10.1183/20734735.0076-2021 Year: 2021 Reading list SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016